Related Experiment Video
Updated: Feb 4, 2026
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
8.5K
Update on Assisted Outpatient Treatment.
Stephanie N Cripps1, Marvin S Swartz2
1Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, 27710, USA.
Current Psychiatry Reports
|October 14, 2018
Summary
Assisted outpatient treatment (AOT) can improve outcomes for individuals with severe mental illness (SMI) who struggle with adherence. Further research is needed to determine when and for whom AOT is most effective.
Area of Science:
- Psychiatry
- Public Health
- Mental Health Services Research
Background:
- Assisted outpatient treatment (AOT) provides court-ordered community-based care for individuals with severe mental illness (SMI).
- Unmet care needs and treatment non-adherence are significant challenges for this population.
- AOT remains a controversial but potentially vital intervention.
Purpose of the Study:
- To review recent research on Assisted Outpatient Treatment (AOT).
- To update on the current status of AOT in the United States.
- To outline future research and implementation directions for AOT.
Main Methods:
- Literature review of recent studies on AOT.
- Analysis of current AOT program effectiveness and sustainability.
- Synthesis of findings to inform future research and policy.
Main Results:
- Recent studies indicate AOT improves treatment engagement and outcomes beyond standard care.
- AOT addresses non-adherence issues in individuals with SMI.
- The sustainability of AOT in the US is linked to federal grant programs.
Conclusions:
- AOT can be effective for individuals with SMI experiencing treatment non-adherence.
- Future research should focus on identifying optimal conditions and patient profiles for AOT.
- Understanding AOT's effectiveness is crucial for supporting this vulnerable population.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
997
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
997
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
952
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
952
01:26Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
01:28Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K